16 results
8-K
EX-99.1
RGEN
Repligen Corp.
12 Apr 23
Regulation FD Disclosure
7:31am
. biopharma o 22,000 sq. ft. o $7M base (non-COVID) revenue FY22 Base with some C&GT o 3 clean rooms (ISO Class 7) o $6-$8M base revenue FY23e o
8-K
EX-10.1
RGEN
Repligen Corp.
31 May 19
Entry into a Material Definitive Agreement
4:01pm
INTENTIONALLY OMITTED
EXHIBIT B
BASE BUILDING CONDITION
Phase 1 Expansion Space
Landlord will deliver Phase 1 Expansion Space in broom clean … in conjunction with Tenantfit-out using the Allowance.
Phase 2 Expansion Space
Landlord will deliver Phase 2 Expansion Space in broom clean “As is” condition
8-K
EX-1.1
r989 kvc7
8 Dec 20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
4:05pm
424B5
wiigy0
1 May 19
Prospectus supplement for primary offering
4:08pm
424B5
vnq7 ntgcbw
29 Apr 19
Prospectus supplement for primary offering
4:40pm
- Prev
- 1
- Next